BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2012
View Archived Issues
Danish company divulges novel CaS receptor agonists
Read More
Novel urate-lowering compound shows potential as a treatment for gout
Read More
Merck Serono patents new GM-CSF-directed immunotherapies
Read More
Results from several dapagliflozin trials disclosed
Read More
Famitinib metabolism investigated in clinical and in vitro studies
Read More
Novel oncolytic targets p53/Mdm2 interaction
Read More
Novel S1P1 receptor modulators reported by Allergan
Read More
Symbicort Turbuhaler obtains additional approval in Japan
Read More
Spanish group presents novel immunomodulators
Read More
Almirall develops new Janus kinase inhibitors
Read More
Stemergie Biotechnology discovers novel agents for cancer
Read More
Alexza provides update on Adasuve submissions
Read More
Ongoing meeting features presentations on PTHrP analogue for postmenopausal osteoporosis
Read More
Two phase III Flutiform trials meet primary endpoint
Read More
Repligen receives complete response letter for RG-1068 NDA
Read More
New agents for RSV infection disclosed by Biota Scientific Management
Read More
European CHMP adopts opinion on teduglutide
Read More
Genkyotex reports phase Ia data on GKT-137831
Read More
Novel prostanoid DP2 receptor antagonists designed in Spain
Read More
Astex kicks off phase II expansion segment of SGI-110 trial
Read More
Cellceutix clear to launch clinical development of anticancer drug
Read More
Theratechnologies gives update on tesamorelin regulatory progress
Read More
EMA committee issues opinion on taliglucerase alfa
Read More
Emend approved for additional indication in Japan
Read More
EMA committee recommends approval of intravenous cephalosporin antibiotic
Read More
Astellas Pharma set to launch Kiklin capsules in Japan
Read More
EMA committee issues opinion on Seebri Breezhaler
Read More